Open Access
The diagnostic role of microRNA 21 in patients with nonsmall cell lung cancer: An exploratory study
Author(s) -
Sumit Rai,
Pankaj Garg,
Shuchi Bhatt,
T Latha,
Amit Verma,
Basu Dev Banerjee,
Mahendra Singh
Publication year - 2020
Publication title -
lung india
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.457
H-Index - 25
eISSN - 0974-598X
pISSN - 0970-2113
DOI - 10.4103/lungindia.lungindia_100_20
Subject(s) - medicine , microrna , lung cancer , oncology , cancer , bioinformatics , genetics , gene , biology
Although histopathological examination of the biopsy specimen is the gold standard for the diagnosis of non small cell lung cancer (NSCLC), a blood-based noninvasive test (liquid biopsy) may prove to be helpful in patients with repeatedly negative biopsy or for response assessment following neoadjuvant therapy. The present study was conducted to explore the diagnostic value of circulating serum microRNA (miRNA) 21 in patients with NSCLC.